Live feed
Filing
SC 13G/A
SC 13G/A0000935836-22-000174·Dyne Therapeutics, Inc.
Schedule 13G ownership disclosure
Dyne Therapeutics Inc
Security class unavailable · CUSIP: 26818M108
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,954,392
- Percent of class
- 5.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-22-000174
- Form type
- SC 13G/A
- Filer
- Dyne Therapeutics, Inc.
- CIK
- CIK 1818794
- Filed
- Feb 14, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership